Kinetic bases of the primary hyperlipidaemias: studies of apolipoprotein B turnover in genetically defined subjects - PubMed (original) (raw)
Kinetic bases of the primary hyperlipidaemias: studies of apolipoprotein B turnover in genetically defined subjects
E D Janus et al. Eur J Clin Invest. 1980 Apr.
Abstract
Autologous 131I-labelled very low density lipoprotein (VLDL) and 125I-labelled low density lipoprotein (LDL) were injected into seven normal subjects and into forty-three hyperlipidaemic patients, classified into groups on the basis of family studies and clinical findings, to quantitate VLDL and LDL apolipoprotein B kinetics. In normal subjects, mean VLDL-B peptide synthetic rate was 15 . 1 mg kg-1 day-1, mean LDL-B peptide synthetic rate 7 . 7 mg kg-1 day-1 and mean LDL-B fractional catabolic rate (FCR) 0 . 31 day-1. In heterozygous familial hypercholesterolaemia (n = 14) VLDL-B peptide production was normal in patients with normal triglyceride levels; in those with high triglyceride levels there was either VLDL overproduction or a catabolic defect. LDL-B peptide synthetic rates ranged from high normal to increased (8 . 5--18 . 0 mg kg-1 day-1) and LDL-B peptide FCR values were markedly reduced (0 . 14--0 . 28 day-1) confirming the presence of a defect in LDL catabolism but indicating over-production as well. In familial combined hyperlipidaemia (n = 11) VLDL-B peptide production ranged from normal to elevated (13 . 9--44 . 4 mg kg-1 day-1, mean 23 . 8 mg kg-1 day-1) correlating with the VLDl triglyceride level (i.e. with the phenotypic expression of the disorder). LDL-B peptide production ranged from high normal to markedly increased (8 . 9--19 . 5 mg kg-1 day-1, mean 12 . 2 mg kg-1 day-1) and correlated with LDL cholesterol levels (i.e. the phenotype), (r = +0 . 66, P < 0 . 05). Three patients with unclassified hypercholesterolaemia had increased LDL-B peptide synthetic rates. One patient with remnant hyperlipoproteinaemia (type III) had a high normal VLDL-B peptide synthetic rate, 17 . 3 mg kg-1 day-1, and a strikingly low FCR of VLDL-B. In familial hypertriglyceridaemia (three patients) there was a low VLDL-B peptide FCR. In unclassified hypertriglyceridaemia VLDL over-production was the finding in seven patients but four patients appeared to have catabolic defects only. Overall there were significant hyperbolic relationships between VLCL-B peptide FCR and VLDL-B peptide concentration (r = -0 . 78, P < 0 . 001, for the log/log relationship) and between LDL-B peptide FCR and LDL cholesterol (r = -0 . 88, P < 0 . 001 for the log/log relationship.)
Similar articles
- Low density lipoprotein metabolism in familial combined hyperlipidemia. Mechanism of the multiple lipoprotein phenotypic expression.
Kissebah AH, Alfarsi S, Evans DJ. Kissebah AH, et al. Arteriosclerosis. 1984 Nov-Dec;4(6):614-24. doi: 10.1161/01.atv.4.6.614. Arteriosclerosis. 1984. PMID: 6508636 - Role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors ("statins") in familial combined hyperlipidemia.
Schonfeld G, Aguilar-Salina C, Elias N. Schonfeld G, et al. Am J Cardiol. 1998 Feb 26;81(4A):43B-46B. doi: 10.1016/s0002-9149(98)00037-x. Am J Cardiol. 1998. PMID: 9526813 Review. - Abnormalities in metabolism of low density lipoproteins associated with coronary heart disease.
Grundy SM, Vega GL, Kesäniemi YA. Grundy SM, et al. Acta Med Scand Suppl. 1985;701:23-37. doi: 10.1111/j.0954-6820.1985.tb08887.x. Acta Med Scand Suppl. 1985. PMID: 3907293 Review.
Cited by
- Effect of apolipoprotein E genotype on apolipoprotein B-100 metabolism in normolipidemic and hyperlipidemic subjects.
Ooi EM, Janus ED, Grant SJ, Sinclair LM, R Barrett PH. Ooi EM, et al. J Lipid Res. 2010 Aug;51(8):2413-21. doi: 10.1194/jlr.M004705. Epub 2010 Apr 22. J Lipid Res. 2010. PMID: 20413671 Free PMC article. Clinical Trial. - FABP4 plasma levels are increased in familial combined hyperlipidemia.
Cabré A, Lázaro I, Cofán M, Jarauta E, Plana N, Garcia-Otín AL, Ascaso JF, Ferré R, Civeira F, Ros E, Masana L. Cabré A, et al. J Lipid Res. 2010 May;51(5):1173-8. doi: 10.1194/jlr.M900066. J Lipid Res. 2010. PMID: 20388924 Free PMC article. - Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus.
Nagashima K, Lopez C, Donovan D, Ngai C, Fontanez N, Bensadoun A, Fruchart-Najib J, Holleran S, Cohn JS, Ramakrishnan R, Ginsberg HN. Nagashima K, et al. J Clin Invest. 2005 May;115(5):1323-32. doi: 10.1172/JCI23219. Epub 2005 Apr 1. J Clin Invest. 2005. PMID: 15841215 Free PMC article. - Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype.
Austin MA. Austin MA. Curr Atheroscler Rep. 2000 May;2(3):200-7. doi: 10.1007/s11883-000-0021-4. Curr Atheroscler Rep. 2000. PMID: 11122745 Review. - The effect of lovastatin on very low-density lipoprotein apolipoprotein B production by the liver in familial combined hyperlipidaemia.
Cortner JA, Bennett MJ, Le NA, Coates PM. Cortner JA, et al. J Inherit Metab Dis. 1993;16(1):127-34. doi: 10.1007/BF00711326. J Inherit Metab Dis. 1993. PMID: 8487493
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials